GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 57 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $12,286,000 | -7.0% | 1,850,373 | -18.5% | 0.73% | -48.1% |
Q1 2020 | $13,211,000 | -31.8% | 2,270,000 | +5.1% | 1.40% | -21.3% |
Q4 2019 | $19,375,000 | -99.9% | 2,160,000 | +22.0% | 1.78% | +12.6% |
Q3 2019 | $15,283,950,000 | -22.5% | 1,770,000 | 0.0% | 1.58% | -14.3% |
Q2 2019 | $19,717,800,000 | +132198.7% | 1,770,000 | +58.0% | 1.85% | +12.8% |
Q1 2019 | $14,904,000 | +33.9% | 1,120,586 | +55.5% | 1.64% | -14.1% |
Q4 2018 | $11,133,000 | +8.5% | 720,586 | 0.0% | 1.90% | +52.8% |
Q3 2018 | $10,261,000 | – | 720,586 | – | 1.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |